In the light of their in vitro effect and early clinical results, antimalarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been proposed for patients with SARS-CoV2- related pneumonia (Covid-19) and are now included in the Chinese guidelines for the management of Covid-19 (version 7, 3 March 2020).
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic / Spinelli, F. R.; Ceccarelli, F.; Di Franco, M.; Conti, F.. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 79:5(2020), pp. 666-667. [10.1136/annrheumdis-2020-217367]
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
Spinelli F. R.
;Ceccarelli F.;Di Franco M.;Conti F.
2020
Abstract
In the light of their in vitro effect and early clinical results, antimalarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been proposed for patients with SARS-CoV2- related pneumonia (Covid-19) and are now included in the Chinese guidelines for the management of Covid-19 (version 7, 3 March 2020).File allegati a questo prodotto
File | Dimensione | Formato | |
---|---|---|---|
Spinelli_Consider-or-Not:2020.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
529.02 kB
Formato
Adobe PDF
|
529.02 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.